Group 6 Copy 391
-1
    Please wait...

    About This Project

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we utilize natural bat colony behavior as a vaccination strategy?

    Bats are one of the most prolific and ecologically important groups of mammals on the planet, but they are often...

    New bioactive peptides from skin of a colombian frog

    The search for alternative antibiotics is on, due to widespread resistance to current antibiotics. We will use...

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Backer Badge Funded

    A medicine project funded by 19 people